Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits glycolytic metabolism in neuroblastoma

15 Nov 2014

Abstract excerpt

// Ann M. Lozier 1 , Maria E. Rich 1 , Anissa Pedersen Grawe 1 , Anderson S. Peck 2 , Ping Zhao 1 , Anthony Ting-Tung Chang 2 , Jeffrey P. Bond 3 and Giselle Saulnier Sholler 1,4 1 Pediatric Oncology Translational Research Program, Helen DeVos Children’s Hospital, Grand Rapids, MI, USA 2 Small Animal Imaging Facility, Van Andel Institute, Grand Rapids, MI, USA 3 University of Vermont, Michigan State University,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Neuroblastoma Research and Treatments
Share to Polyamine Metabolism and Applications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25415050
DOI: 10.18632/oncotarget.2768

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits glycolytic metabolism in neuroblastomaPMID 25415050Read ↗

Disrupting Polyamine Homeostasis as a Therapeutic Strategy for NeuroblastomaSemantic proximity Read ↗

Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastomaSemantic proximity Read ↗

High-dose DFMO alters protein translation in neuroblastomaSemantic proximity Read ↗

Amino Acid Metabolism Subtypes in Neuroblastoma Identifying Distinct Prognosis and Therapeutic Vulnerabilities.Semantic proximity Read ↗

Deoxyhypusine synthase (DHPS) inhibitor GC7 induces p21/Rb-mediated inhibition of tumor cell growth and DHPS expression correlates with poor prognosis in neuroblastoma patientsSemantic proximity Read ↗

MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastomaSemantic proximity Read ↗

Polyamine Metabolism Is Sensitive to Glycolysis Inhibition in Human Neuroblastoma CellsSemantic proximity Read ↗

Metabolic targeting of neuroblastoma, an updateSemantic proximity Read ↗

Reprogramming neuroblastoma by diet-enhanced polyamine depletionSemantic proximity Read ↗

High-dose DFMO alters protein translation in neuroblastomaSemantic proximity Read ↗

DFMO/eflornithine inhibits migration and invasion downstream of MYCN and involves p27Kip1 activity in neuroblastomaSemantic proximity Read ↗

Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and ProgressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.